Advertisement
Home »

Fracture risk in women with osteoporosis initiated on gastro-resistant risedronate versus immediate release risedronate or alendronate: a claims data analysis in the USA.

Mar 06, 2023

ABOUT THE EXPERTS

  • John A Eisman

    Bone Biology Division, Garvan Institute of Medical Research, Darlinghurst, Australia.

    School of Medicine Sydney, University of Notre Dame Australia, Sydney, Australia.

    St Vincent’s Hospital, UNSW Sydney, NSW, Sydney, Australia.

    Bernard Cortet

    Service de Rhumatologie, Centre Hospitalier Universitaire de Lille, Lille, France.

    Mitra Boolell

    Theramex, Sloane Square House 1 Holbein Place Belgravia, London, SW1W 8NS, UK. Mitra.Boolell@theramex.com.

    Raluca Ionescu-Ittu

    STATLOG, Montreal, Canada.

    Francis Vekeman

    STATLOG, Montreal, Canada.

    Julie Heroux

    Heroux Consulting, The Hague, Netherlands.

    Friederike Thomasius

    Frankfurter Hormon Und Osteoporosezentrum, Frankfurt, Germany.

REFERENCES & ADDITIONAL READING

PubMed

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

Advertisement